Shu Jen Chen

Dr. Shu Jen Chen is the Co-founder and Chief Scientific Officer of ACT Genomics Co., Ltd. She has gained in-depth knowledge and experience in cancer biology, drug discovery and development, and bioinformatics for over 20 years.